European Commission logo
English English
CORDIS - EU research results
CORDIS

Standardised administration device for raw medical herbs

Project description

New inhaler for herbal medicines

The use of medicinal plants is as old as the existence of humankind. The World Health Organization estimates that 80 % of the world's population is using products based on medicinal herbs. Around the world, the interest in natural medicine, particularly in phytotherapy (herbal medicine), is increasing. The next step is to standardise the administration of medicinal herbs. The In-Heal project has developed a smart vaporiser for medicinal herbs. Its device enables very efficient and precise dosing of useful ingredients by vaporising valuable active ingredients from raw herbs directly, without the emission of any harmful compounds. The main objective is to develop the first medical-grade inhaler device for controlled administration of medical herbs. Phase 1 of the project involves the preparation of the business plan.

Objective

In the recent years public interest towards natural medicine in particular to phytotherapy (herbal medicine) is increasing. However, the administration of medicinal herbs is not yet standardised and medically acceptable administration device is still not commercially available. We have developed high-end smart vaporiser for medicinal herbs. Our In-Heal device enables very efficient and precise dosing of useful ingredients by vaporising valuable active ingredients from raw herbs directly, without the emission of any harmful compounds as opposed to combustion (e.g. e-cigarettes). Our overall objective is to provide the world’s first medical grade inhaler device for controlled administration of medical herbs. We aim to revolutionize the use of medical herbs by standardising their administration and dosage. In the future we need to carry out clinical validation, establish necessary partnership, prepare for serial production, as well as seek for furher grants and investment to support these activities. Phase 1 objective: preparation for clinical validation, investor ready business plan.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

HUNIFY LABORATORIES FEJLESZTO ES SZOLGALTATO KFT
Net EU contribution
€ 50 000,00
Address
REPULOTERI UTCA 2 A EP
1097 Budapest
Hungary

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Közép-Magyarország Budapest Budapest
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00